Skip to content

SimuPlus™ 7700FB34 (UDI 00763000271329)Recalls & reported problems

Medtronic, Inc. · Band 7700FB34 SimuPlus Flex 34mm GLB · Class 2 · Implant

All models of SimuPlus (24)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
16
Deaths reported
0
Injuries reported
16
Recalls naming it
0

Summary

The FDA's MAUDE database contains 16 adverse event reports that list this exact device (DI 00763000271329), received between Aug 29, 2022 and Apr 8, 2026 — classified as 16 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (9 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 2 reportsAug 2024: 1 reportsSep 2024: 1 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 1 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information9
  • Adverse Event Without Identified Device or Use Problem7
  • Intravalvular regurgitation3
  • Appropriate Device Problem Term/Code Not Available1

Patient problems

  • Insufficient Information11
  • Mitral Valve Insufficiency/ Regurgitation6
  • Atrial Fibrillation1
  • Bradycardia1
  • Cardiomyopathy1
  • Heart Failure/Congestive Heart Failure1
  • Non specific EKG/ECG Changes1

Recent adverse event reports

The 16 most recent of 16 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 8, 2026Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT 1 YEARS AND 3 MONTHS POST IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH A 38MM MITRAL ANNULOPLASTY BAND OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 24815201 ↗
  • InjuryFeb 17, 2026Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT 1 DAY POST IMPLANT OF THIS 34MM SIMUPLUS ANNULOPLASTY HEART BAND, IT WAS EXPLANTED AND REPLACED WITH A NON-MEDT RONIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 24363202 ↗
  • InjuryDec 17, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ADDITIONAL INFORMATION RECEIVED REPORTED THE REASON FOR INTERVENTION AS RESIDUAL REGURGITATION. THE DEVICE DID NOT MALFUNCTION AND THE DEVICE WAS FULLY SUTERED AND TESTED PRIOR TO REMOVAL. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 23826055 ↗
  • InjuryJun 30, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS REPORTED THAT POST IMPLANT OF THIS 34 M ANNULOPLASTY BAND, A DEFIBRILLATOR WAS IMPLANTED. THE REASON FOR THE DEFIBRILLATOR IMPLANT WAS REPORTED AS CARDIOMYOPATHY. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Cardiomyopathy

    MAUDE report 22358833 ↗
  • InjuryJan 27, 2025Insufficient Device Problem Information; Intravalvular regurgitation; Insufficient Device Problem Information; Intravalvular regurgitation

    IT WAS REPORTED THAT POST IMPLANT OF THIS 34MM SIMUPLUS MITRAL BAND, IT WAS EXPLANTED AND REPLACED WITH A 33MM MOSAIC MITRAL VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information; Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 21240099 ↗
  • InjuryOct 21, 2024Insufficient Device Problem Information; Appropriate Device Problem Term/Code Not Available; Insufficient Device Problem Information; Appropriate Device Problem Term/Code Not Available

    ADDITIONAL INFORMATION WAS RECEIVED THAT REPORTED THE 34MM MITRAL ANNULOPLASTY BAND WAS NOT EXPLANTED, AS IT WAS RE-POSITIONED AND TIGHTENED DURING THE PROCEDURE. A 34MM TRICUSPID ANNULOPLASTY BAND WAS IMPLANTED CONCOMITANTLY DURING THIS PROCEDURE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 20500134 ↗
  • InjurySep 20, 2024Intravalvular regurgitation; Intravalvular regurgitation

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT PROCEDURE, A 34MM MITRAL ANNULOPLASTY BAND AND A 40MM MITRAL ANNULOPLASTY BAND WERE BOTH ATTEMPTED AND REPLACED WITH A 42MM MITRAL ANNULOPLASTY BAND OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS REPORTED AS MODERATE REGURGITATION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 20268568 ↗
  • InjuryAug 27, 2024Insufficient Device Problem Information; Intravalvular regurgitation; Insufficient Device Problem Information; Intravalvular regurgitation

    MEDTRONIC RECEIVED INFORMATION THAT 6 DAYS POST IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH A 29MM BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information; Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 20075840 ↗
  • InjuryJul 23, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PRODUCT. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 19809211 ↗
  • InjuryJul 22, 2024Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN DEVICE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 19793976 ↗
  • InjuryJun 4, 2024Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN DEVICE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. IT WAS REPORTED THAT, "THIS WAS A FAILED REPAIR AND NOT DUE TO THE BAND. HAD TO BE REPLACED." NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 19464113 ↗
  • InjuryMar 14, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT 3 DAYS POST IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, AN ELECTROCARDIOGRAM (ECG) PERFORMED NOTED PREMATURE ATRIAL COMPLEXES. SUBSEQUENTLY 4 DAYS LATER, A SECOND ECG PERFORMED NOTED ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE AND INCOMPLETE RIGHT BUNDLE BRANCH BLOCK (RBBB). ONE DAY LATER, SINUS BRADYCARDIA WAS NOTED ON ECG. THE CONDUCTION DISTURBANCES PROLONGED HOSPITALIZATION. NO INTERVENTION OR ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Atrial Fibrillation; Bradycardia; Non specific EKG/ECG Changes

    MAUDE report 18905327 ↗
  • InjuryDec 19, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PRODUCT. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 18355412 ↗
  • InjurySep 27, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT 9 MONTHS POST IMPLANT POST IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, THE PATIENT WAS ADMITTED TO THE EMERGENCY DEPARTMENT WITH ACUTE ON SET CHRONIC HEART FAILURE. IT WAS REPORTED THAT 2 DAYS LATER, AFTER A CARDIAC SURGERY CONSULT, DIURETICS WERE ADMINISTERED DUE TO BLOOD VOLUME OVERLOAD AND HEART FAILURE. IT WAS REPORTED THAT 24DAYS LATER, AN ECHOCARDIOGRAM (ECHO) PERFORMED NOTED THICKENED NATIVE MITRAL LEAFLETS WITH RESTRICTED POSTERIOR NATIVE MITRAL VALVE LEAFLET, MODERATE TO SEVERE MITRAL REGURGITATION. (MR) AND MODERATELY DECREASED RIGHT VENTRICLE (RV) SYSTOLIC FUNCTION. ONE DAY LATER, THE 34MM MITRAL ANNULOPLASTY BAND WAS EXPLANTED AND REPLACED WITH A NON MEDTRONIC PRODUCT. IT WAS STATED THAT DURING THE EXPLANT PROCEDURE, THE PATIENT'S TRICUSPID NATIVE VALVE WAS ALSO REPAIRED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Heart Failure/Congestive Heart Failure; Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 17827452 ↗
  • InjurySep 9, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH A 40MM BAND OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS REPORTED AS RESIDUAL MITRAL REGURGITATION. IT WAS REPORTED THAT THE 34MM MITRAL ANNULOPLASTY BAND DID NOT MALFUNCTION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 15391777 ↗
  • InjuryAug 29, 2022Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 34MM MITRAL ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PRODUCT. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information; Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 15316468 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page